Wolf B, Grohmann R, Biber D, Brenner P M, Rüther E
Department of Psychiatry, Ludwig-Maximilians-University, Munich, FRG.
Pharmacopsychiatry. 1989 Mar;22(2):54-60. doi: 10.1055/s-2007-1014578.
Over a period of five and a half years, 792 inpatients with benzodiazepine (BZD) abuse and dependence in accordance with the WHO definition were registered at a university psychiatric hospital. One-quarter of them abused BZD exclusively, while three-quarters suffered from polytoxicomania or were alcohol dependent as well. It was possible to distinguish two groups of patients: one with primary, mainly low-dose, dependence preferring lorazepam and the other with secondary, often high-dose, dependence with diazepam as the main drug. In 108 patients with isolated BZD dependence, withdrawal symptoms of somatic, psychological, or perceptual quality were observed. The severity of the withdrawal syndrome seemed to depend on the time of consumption, dose, mode of withdrawal, and type of BZD compound. Following abrupt cessation, 11 patients with long-standing dependence on high BZD doses developed withdrawal psychoses, presenting a delirious, paranoid-hallucinatory, or depressive-anxious syndrome.
在五年半的时间里,一家大学精神病医院登记了792名符合世界卫生组织定义的苯二氮䓬(BZD)滥用和依赖的住院患者。其中四分之一的患者仅滥用BZD,而四分之三的患者患有多种药物成瘾或同时存在酒精依赖。可以区分出两组患者:一组为原发性,主要是低剂量依赖,偏好劳拉西泮;另一组为继发性,通常是高剂量依赖,以地西泮为主要药物。在108例单纯BZD依赖患者中,观察到了躯体、心理或感知方面的戒断症状。戒断综合征的严重程度似乎取决于用药时间、剂量、戒断方式和BZD化合物类型。在长期高剂量依赖BZD的患者突然停药后,11例出现了戒断性精神病,表现为谵妄、偏执幻觉或抑郁焦虑综合征。